Class II recall: Apotex Corp.: Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only

Apotex Corp. issued a Class II recall for Paxil CR (paroxetine extended-release tablets), 37.5mg, 30-count bottles, NDC 60505-4379-3. According to the FDA recall notice, the product failed to meet 24-month stability testing acceptance criteria due to failed dissolution specifications.

Most relevant for: Patients prescribed paroxetine extended-release 37.5mg tablets from the affected lot for depression or other approved indications.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.